Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NAMSW
#8524
NewAmsterdam Pharma Company N.V. Ordinary Shares
23.200
0
+0.22%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.22%
Aylık değişim
+12.62%
6 aylık değişim
+68.06%
Yıllık değişim
+159.80%
Önceki kapanış
23.150
0
Open
23.180
0
Bid
Ask
Low
23.180
0
High
23.200
0
Hacim
2
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NAMSW
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
92.39 M
109.82 M
112.27 M
112.63 M
113.39 M
114.98 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
—
Price to earnings ratio
-3.11
-5.57
-4.89
-5.06
-8.51
-13.43
-31.89
Price to sales ratio
19.2
29.51
17.98
12.53
52.31
121.57
204.39
Price to cash flow ratio
-4.01
-8.48
-6.26
-6.85
-13.06
-18.51
-44.69
Price to book ratio
0.42
1.78
0.39
0.31
0.62
4
5.33
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.04
0.11
0.05
0.02
0.09
0.1
0.26
Return on equity %
0.04
0.12
0.05
0.02
0.1
0.11
0.28
Return on invested capital %
301.17
—
—
—
259.21
450.78
—
Gross margin %
100
63.69
-96.14
77.6
-816.95
-31.09 K
-31.92 K
Operating margin %
85.89
338.47
2 314.47
186.13
15.85 K
206.19 K
224.53 K
EBITDA margin %
—
-374.38
-2 508.87
-208.3
-16.74 K
-237.19 K
-256.65 K
Net margin %
57.18
721.71
1 327.3
90.7
20.69 K
234.13 K
256.24 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
10.61
8.08
19.98
21.08
12.57
7.88
61.51
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.02
0
0.02
0
0
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.13
0.4
0.31
0.32
0.28
0.35
1.25
EBIT per share
—
-0.51
-0.64
-0.34
-0.49
-0.64
-2.11
EBITDA per share
—
-0.51
-0.64
-0.34
-0.49
-0.64
-2.11
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.46
8.18
6.96
6.23
5.91
5.37
24.48
Net current asset value per share
4.62
9.15
7.04
6.49
6.15
5.71
25.39
Tangible book value per share
3.99
8.02
6.69
6.56
6.11
5.77
25.13
Working capital per share
4.19
8.02
6.69
6.19
5.66
4.98
23.52
Book value per share
4
8.03
6.69
6.57
6.12
5.77
25.15
Haberler
NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating (NASDAQ:NAMS)
abrdn Life Sciences Investors Q1 2025 Commentary
abrdn World Healthcare Fund Q4 2024 Commentary (NYSE:THW)